For example, a third-generation CAR consisting of α-CD19/CD3ζ/CD28/4−1BB segments dramatically increased the rate of complete recovery in patients with CLL by penetrating and lysing tumor cells (134). This evidence concerns the gene CD19 and neoplasm.